July 2026
The oncology market size surpassed USD 250.88 billion in 2025 and is expected to hit around USD 732.45 billion by 2035 with a CAGR of 11.31%.
June 2026
Oncology proteomics market to grow significantly by 2035, driven by cancer research advances, biomarker discovery, and rising demand for precision medicine.
March 2026
The global oncology information system market size is expected to be hit around USD 6.95 billion by 2035 from USD 3.21 billion in 2025, with a CAGR of 8.03%.
September 2025
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
July 2025
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
June 2025
The global oncology molecular diagnostic market size was valued at USD 2.74 billion in 2024 and is expected to surge around USD 8.50 billion by 2034, at a CAGR of 11.99%.
June 2025
The global oncology clinical trials market size is expected to worth around USD 22.76 billion by 2034 from USD 13.60 billion in 2024 with a CAGR of 5.28%.
July 2026
The global immuno-oncology antibodies market is growing. Learn about market drivers, therapeutic applications, and the companies driving innovation.
July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
February 2026
The global interventional oncology market size was evaluated at USD 2.94 billion in 2025 and is predicted to hit around USD 6.73 billion by 2035, growing at a CAGR of 8.63%.
February 2026
The global digital twin in oncology market size was evaluated at USD 450.00 million in 2025 and is predicted to hit around USD 7226.90 million by 2035, growing at a CAGR of 32.00%.
February 2026
The global oral oncology specialty pharmacy market is driven by rising cancer burden, increasing use of oral anticancer drugs, and expansion of specialty pharmacy services worldwide.
January 2026
The artificial intelligence (AI) in oncology market size is expected to hit around USD 21.36 billion by 2035 from USD 1.87 billion in 2025 with a CAGR of 27.58%.
January 2026
The global veterinary oncology market size is estimated to hit around USD 5.60 billion by 2035, increasing from USD 1.82 billion in 2025, with a CAGR of 11.90%.
December 2025
The global precision oncology market size is calculated at USD 133 billion in 2025 and is projected to hit around USD 338.89 billion by 2035 with a CAGR of 11.33%.
December 2025
The global non-oncology precision medicine market size is calculated at USD 92.21 billion in 2025 and is projected to hit around USD 222.95 billion by 2035 with a CAGR of 9.23%.
December 2025
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
July 2025
Explore the pan-tumor oncology treatment market, driven by breakthroughs in immunotherapy, targeted treatments, and the rise of tumor-agnostic drug approvals across multiple cancer types.
July 2025
The U.S. oncology molecular diagnostics market size is projected to surge USD 2,500 million by 2034 from USD 790 million in 2024 with a notable CAGR of 12.21%.
July 2025
The global outpatient oncology infusion market size is predicted to attain around USD 244.03 billion by 2034 from USD 87.17 billion in 2024 with a notable CAGR of 10.84%.
July 2026
Phase?Ib gene editing trials market fueled by base editing therapies targeting PCSK9 and hereditary diseases, anticipating steep growth through 2030+.
August 2025
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
August 2025
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%.
July 2025
The epigenetics diagnostics market size was evaluated at USD 16.90 billion in 2024 and is predicted to worth around USD 67.26 billion by 2034, with a CAGR of 14.81%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com